NO307546B1 - Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav - Google Patents

Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav

Info

Publication number
NO307546B1
NO307546B1 NO952418A NO952418A NO307546B1 NO 307546 B1 NO307546 B1 NO 307546B1 NO 952418 A NO952418 A NO 952418A NO 952418 A NO952418 A NO 952418A NO 307546 B1 NO307546 B1 NO 307546B1
Authority
NO
Norway
Prior art keywords
ketorolac
pain
optically pure
pharmaceutical composition
composition containing
Prior art date
Application number
NO952418A
Other languages
English (en)
Norwegian (no)
Other versions
NO952418D0 (no
NO952418L (no
Inventor
Timothy J Barberich
Stephen L Matson
William J Wechter
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of NO952418D0 publication Critical patent/NO952418D0/no
Publication of NO952418L publication Critical patent/NO952418L/no
Publication of NO307546B1 publication Critical patent/NO307546B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO952418A 1992-12-17 1995-06-16 Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav NO307546B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US99198192A 1992-12-17 1992-12-17
PCT/US1993/012299 WO1994013283A1 (en) 1992-12-17 1993-12-17 Antipyretic and analgesic methods and compositions containing optically pure r-ketorolac

Publications (3)

Publication Number Publication Date
NO952418D0 NO952418D0 (no) 1995-06-16
NO952418L NO952418L (no) 1995-08-03
NO307546B1 true NO307546B1 (no) 2000-04-25

Family

ID=25537797

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952418A NO307546B1 (no) 1992-12-17 1995-06-16 Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav

Country Status (14)

Country Link
US (1) US5382591A (fi)
EP (1) EP0674511B1 (fi)
JP (1) JP2957701B2 (fi)
KR (1) KR100264814B1 (fi)
AT (1) ATE150969T1 (fi)
AU (1) AU696620B2 (fi)
CA (1) CA2151724C (fi)
DE (1) DE69309492T2 (fi)
DK (1) DK0674511T3 (fi)
ES (1) ES2100046T3 (fi)
FI (1) FI952985A (fi)
GR (1) GR3023741T3 (fi)
NO (1) NO307546B1 (fi)
WO (1) WO1994013283A1 (fi)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac
US5981592A (en) * 1995-03-13 1999-11-09 Loma Linda University Medical Center Method and composition for treating cystic fibrosis
US5955504A (en) * 1995-03-13 1999-09-21 Loma Linda University Medical Center Colorectal chemoprotective composition and method of preventing colorectal cancer
US6160018A (en) * 1995-03-13 2000-12-12 Loma Linda University Medical Center Prophylactic composition and method for alzheimer's Disease
EP1642575B1 (en) * 1997-03-10 2009-10-28 Loma Linda University Medical Center Use of r-carprofen for the prevention of alzheimer's disease
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6576191B1 (en) * 1999-09-30 2003-06-10 Therox, Inc. Apparatus for blood oxygenation
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
AU2001257022B2 (en) * 2000-04-13 2005-02-03 Mayo Foundation For Medical Education And Research Abeta 42 lowering agents
US20030027867A1 (en) * 2001-06-29 2003-02-06 Myriad Genetics, Incorporated Use of R-NSAID compounds for anti-HIV treatment
WO2003068159A2 (en) * 2002-02-11 2003-08-21 Wake Forest University Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS
KR20060040676A (ko) * 2003-07-11 2006-05-10 미리어드 제네틱스, 인크. 알츠하이머병을 치료하기 위한 약제학적 방법, 투약 방법및 제형
DK1654002T4 (da) 2003-08-07 2014-02-17 Allergan Inc Sammensætninger til fremføring af terapeutiske midler til øjnene
US20070293538A1 (en) * 2004-04-13 2007-12-20 Myriad Genetics, Incorporated Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
CN1946906A (zh) * 2004-04-29 2007-04-11 吉斯通护岸系统股份有限公司 用于墙、护墙和类似物的饰面
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020853A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
JP2009502807A (ja) * 2005-07-22 2009-01-29 ミリアド ジェネティクス， インコーポレイテッド 薬剤含有率の高い製剤および投与量形態
WO2008006099A2 (en) * 2006-07-07 2008-01-10 Myriad Genetics, Inc. Treatment of psychiatric disorders
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
MX2008003230A (es) * 2008-03-07 2009-09-07 Senosiain S A De C V Lab Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
CN112094271B (zh) * 2019-06-18 2023-03-21 鲁南制药集团股份有限公司 一种酮咯酸晶型及其制备方法
CN110540542A (zh) * 2019-09-12 2019-12-06 南京海融制药有限公司 一种苯乙酸类化合物的钠盐、结晶形式及其制备方法
CN115279367B (zh) * 2020-02-24 2024-02-20 长春亿诺科医药科技有限责任公司 用于治疗细胞因子风暴和细胞因子释放综合征的组合物和方法
CN114276350B (zh) * 2020-09-28 2023-05-16 鲁南制药集团股份有限公司 一种酮咯酸与吩嗪共晶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
EP0264429A4 (en) * 1986-04-16 1990-03-12 Wisconsin Alumni Res Found ENZYMATIC PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE 1,2-DIHYDRO-3H-PYROLLO 1,2a] PYRROLE-1-CARBOXYLIC ACID DERIVATIVES.
WO1991013609A1 (en) * 1990-03-16 1991-09-19 The Procter & Gamble Company Use of ketorolac for treatment of periodontal disease
JP3541849B2 (ja) * 1991-04-19 2004-07-14 久光製薬株式会社 消炎鎮痛貼付剤
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac

Also Published As

Publication number Publication date
CA2151724C (en) 2000-10-31
US5382591A (en) 1995-01-17
FI952985A0 (fi) 1995-06-16
EP0674511A1 (en) 1995-10-04
KR100264814B1 (ko) 2000-09-01
NO952418D0 (no) 1995-06-16
JP2957701B2 (ja) 1999-10-06
ES2100046T3 (es) 1997-06-01
DE69309492D1 (de) 1997-05-07
DE69309492T2 (de) 1997-07-10
CA2151724A1 (en) 1994-06-23
AU5872194A (en) 1994-07-04
JPH08505133A (ja) 1996-06-04
DK0674511T3 (da) 1997-04-21
GR3023741T3 (en) 1997-09-30
EP0674511B1 (en) 1997-04-02
AU696620B2 (en) 1998-09-17
ATE150969T1 (de) 1997-04-15
NO952418L (no) 1995-08-03
WO1994013283A1 (en) 1994-06-23
KR950703951A (ko) 1995-11-17
FI952985A (fi) 1995-08-16

Similar Documents

Publication Publication Date Title
NO307546B1 (no) Farmasøytisk preparat inneholdende optisk ren R-ketorolak samt anvendelse derav
RU94042899A (ru) Способ достижения болеутоляющего эффекта, способ лечения и профилактики гипертермии у человека, болеутоляющая и жаропонижающая композиции, содержащие оптически чистый r (-) кетопрофен
EP0727994A4 (en) ANTIPYRETIC AND ANALGESIC METHODS AND COMPOSITIONS CONTAINING OPTICALLY PURE ETODOLIC ACID
NO960067L (no) Nytt farmasöytisk preparat
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
DK1137416T3 (da) Anvendelse af langkædede N-alkylderivater af deoxynojirimycin til fremstilling af et lægemiddel til behandling af glycolipidophobnings-sygdomme
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
FI973163A0 (fi) Pidätyskyvyttömyyden hoitaminen käyttämällä (S)-oksibutyniiniä ja (S)-desetyylioksibutyniiniä
EP1022025A3 (en) Method and compositions for treating emesis nausea and other disorders using optically pure R(+) ondansetron
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
PT88985A (pt) Processo para a preparacao de composicoes farmaceuticas nasais e ou oftalmicas contendo azelastina
HUP9904360A2 (hu) Eljárás emesis és központi idegrendszeri rendellenességek kezelésére, optikailag tiszta (+)-norciszaprid alkalmazásával
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
ATE107168T1 (de) Verwendung von gepiron zur herstellung eines pharmazeutischen präparats zur behandlung atypischer depression.
ES555118A0 (es) Metodo de preparar medicamentos que incluyen un agente buscador de hueso y un inhibidor de anhidrasa carbonica, para impedir y curar enfermedades oseas.
DK0871446T3 (da) Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve
PT98764A (pt) Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos
ATE147978T1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
DK0769945T3 (da) Brug af 2-phenyl-3-aroylbenzothiophenderivater til fremstilling af et medikament til behandling af knogler og knoglebrud
DK0453337T3 (da) Anvendelse af hexetidin eller derivater eller salte deraf til fremstilling af et farmaceutisk præparat til oftalmologisk anvendelse
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
RU95113855A (ru) Способ консервативного лечения ожогов глаз
RU93008441A (ru) Способ длительной антистрессорной терапии у хирургических больных
YU15301A (sh) PRIMENA R (+)- alfa-(2,3-DIMETOKSIFENIL)-1-[2-(4-FLUOROFENIL) ETIL] -4-PIPERIDINMETANOLA ZA LECENJE POREMEĆAJA SPAVANJA

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2002